Polaris Market Research today announced findings from its latest report, projecting the global Oligonucleotide Synthesis Market to grow from USD 3.55 billion in 2025 to USD 12.49 billion by 2034, at a CAGR of 15.01% between 2026 and 2034. The report profiles 14 leading companies across five market segments: product, application, end user, technology or chemistry, and region.

Analyst Commentary on Oligonucleotide Synthesis Market Growth

“Oligonucleotide-based medicines are moving from niche to mainstream, and that shift is lifting demand for custom synthesis, purification, and manufacturing capacity across the industry,” said a senior analyst at Polaris Market Research. “The opportunity lies with service providers and CDMOs that can deliver longer, modified sequences at scale as enzymatic synthesis and automation mature.”

The market is estimated at USD 4.07 billion in 2026. Services was the largest product segment in 2025 with 38.24% of revenue, as pharmaceutical, biotechnology, and research organizations increasingly outsource synthesis and purification instead of investing in in-house production systems. Several companies have also secured regulatory accreditation for their manufacturing facilities.

Oligonucleotide Synthesis Market Statistics at a Glance

• 2025 Market Size: USD 3.55 Billion
• 2034 Projected Size: USD 12.49 Billion
• CAGR (2026-2034): 15.01%
• Largest Region (2025): North America, 40.9% share

Key Growth Drivers, Major Companies and Segments Covered

Growth Drivers: Rising demand for oligonucleotide-based medicines, growing investment in advanced manufacturing, and wider use in molecular diagnostics and genetic testing are the primary forces behind the market's expansion, alongside growing demand for siRNA and antisense therapeutics. In 2026, Aragen Life Sciences announced plans to add 500 kiloliters of new CDMO capacity, with oligonucleotides among its focus areas. High manufacturing complexity, especially for longer and modified sequences, remains the main restraint.

Major Companies Covered: Agilent Technologies, Thermo Fisher Scientific, Merck KGaA, GenScript Biotech, Integrated DNA Technologies, Eurofins Genomics, LGC Biosearch Technologies, TriLink BioTechnologies, and Twist Bioscience, among others.

Segments Covered: By Product (Synthesized Oligonucleotide Products, Equipment, Reagents, Services), By Application (PCR Primers, PCR Assays and Panels, DNA Microarrays, Sequencing, Antisense Oligonucleotides, FISH), By End User, By Technology/Chemistry (Phosphoramidite Chemistry, Solid-Phase Synthesis, Liquid-Phase Synthesis, Enzymatic Synthesis), By Region.

👉 Download a Free Sample of the Oligonucleotide Synthesis Market Report →

https://www.polarismarketresearch.com/industry-analysis/oligonucleotide-synthesis-market 

Segment Insights: PCR Primers, Academic Users, and Solid-Phase Chemistry Lead

PCR primers led applications with 20.4% of revenue in 2025, while antisense oligonucleotides are projected to grow at a 15.9% CAGR through 2034. Academic and research institutes were the largest end user with 44.9% of revenue, whereas pharmaceutical and biotechnology companies are expected to grow at a 16.5% CAGR.

Chemical and solid-phase synthesis held 66.2% of revenue in 2025 and remains the dominant technology. Enzymatic synthesis, however, is projected to expand at an 18.6% CAGR as demand rises for longer and more complex sequences in gene editing, cell therapy, and synthetic biology.

Technology is reshaping production economics. Automation and high-throughput systems allow laboratories to process more sequences with less manual work, while AI-assisted sequence design and improved purification help developers handle complex oligonucleotides. In February 2026, the FDA launched a framework for individualized therapies for ultra-rare diseases, opening new avenues for customized nucleic acid medicines.

Recent Developments in the Oligonucleotide Synthesis Market

• July 2026: DNA Script signed a distribution agreement with Imperial Life Sciences to expand access to its SYNTAX on-demand DNA synthesis platform in India.
• July 2026: Oligo Factory launched NGS Unique-Dual Indexed Stubby Adapter Kits to support next-generation sequencing workflows.
• July 2025: AstraZeneca announced plans to invest USD 50 billion in the U.S. by 2030, including a large-scale Virginia facility for small molecules, peptides, and oligonucleotides.
• 2026: Agilent launched Agilent Advanced Therapeutics to unify its CDMO capabilities, including oligonucleotide manufacturing, across North America.
• May 2025: Oligo Factory launched a low-scale oligo synthesis capability at its Holliston, Massachusetts facility to broaden support for therapeutic and diagnostic developers.

Regional Snapshot: North America Leads, Asia Pacific Fastest-Growing

North America led with 40.9% share in 2025, supported by a prominent pharmaceutical and biotechnology sector, substantial R&D investment, and rising genomic and gene therapy activity, while Asia Pacific is projected to register the fastest CAGR of 17.5% through 2034 on the back of growing biotechnology investment, genomics research, and personalized medicine, with China, Japan, and India seeing increased activity.

Why It Matters for Buyers Evaluating the Oligonucleotide Synthesis Market Forecast

For stakeholders researching top oligonucleotide synthesis companies and the oligonucleotide synthesis market forecast to 2034, the underlying report benchmarks Oligonucleotide Synthesis Market share, company positioning, and segment-level forecasts to support sourcing, partnership, and investment decisions through 2034.

The market remains fragmented, with companies competing on synthesis quality, purification capabilities, and regulator-accredited manufacturing. Use cases span PCR testing, cancer biomarker detection, CRISPR gene editing, drug discovery, and infectious disease testing, giving suppliers multiple routes to growth through 2034.

About Polaris Market Research

Polaris Market Research is a B2B syndicated market research and consulting firm offering 5,000+ published reports across 20+ industry verticals, delivering data-backed insights to help businesses make informed decisions.

More Trending Latest Reports By Polaris Market Research:

corn-market

variable-frequency-drive-market

industrial-mixers-market

legal-services-market

cryptocurrency-market

https://www.polarismarketresearch.com/press-releases/it-services-market

dermatology-drugs-market

landscaping-services-market

synthetic-data-generation-market